DSE : BXPHARMA

Beximco Pharmaceuticals PLC. — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 143 BDT (At close: Oct 28, 2026) · Market cap 64.11B

Latest research: Beximco Pharmaceuticals valuation report: fair value BDT 99.2–218 (Oct 2026) · Beximco Pharmaceuticals: fair value BDT 99–218 as FY2026 EPS rises 30% to BDT 20.17

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap64.11B
Enterprise Value65.53B

Dates

MeasureValue
Earnings DateNov 3, 2026
Ex-Dividend DateNov 22, 2026

Shares

MeasureValue
Current Share Class446.11M
Shares Outstanding446.11M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)0.08%
Floatn/a

Ratios

MeasureValue
PE Ratio7.41
Forward PE6.46
PS Ratio1.19
PB Ratio1.00
P/TBV Ratio1.17
P/FCF Ratio8.85
P/OCF Ratio6.12
PEG Ration/a

Evratios

MeasureValue
EV / Earnings7.58
EV / Sales1.22
EV / EBITDA4.96
EV / EBIT5.78
EV / FCF9.05

Financialposition

MeasureValue
Current Ratio4.13
Quick Ratio1.40
Debt / Equity0.05
Debt / EBITDA0.24
Debt / FCF0.44
Interest Coverage16.64

Financialefficiency

MeasureValue
Return on Equity (ROE)14.71%
Return on Assets (ROA)9.22%
Return on Invested Capital (ROIC)14.31%
Return on Capital Employed (ROCE)15.75%
Weighted Average Cost of Capital (WACC)6.32%
Revenue Per Employee44.09M
Profits Per Employee7.07M
Employee Count1,223
Asset Turnover0.70
Inventory Turnover1.86

Taxes

MeasureValue
Income Tax2.53B
Effective Tax Rate22.36%

Stockprice

MeasureValue
Beta (5Y)0.28
52-Week Price Change+25.83%
50-Day Moving Average146.41
200-Day Moving Average130.55
Relative Strength Index (RSI)44.98
Average Volume (20 Days)446,955

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue53.93B
Gross Profit25.57B
Operating Income11.33B
Pretax Income11.32B
Net Income8.65B
EBITDA13.11B
EBIT11.33B
Earnings Per Share (EPS)19.39

Balancesheet

MeasureValue
Cash & Cash Equivalents5.78B
Total Debt3.16B
Net Cash2.62B
Net Cash Per Share5.87
Equity (Book Value)64.10B
Book Value Per Share134.60
Working Capital21.26B

Cashflow

MeasureValue
Operating Cash Flow10.47B
Capital Expenditures-3.23B
Depreciation & Amortization1.78B
Net Borrowing-4.33B
Free Cash Flow7.24B
FCF Per Share16.23

Margins

MeasureValue
Gross Margin47.42%
Operating Margin21.01%
Pretax Margin20.99%
Profit Margin16.04%
EBITDA Margin24.31%
EBIT Margin21.01%
FCF Margin13.43%

Dividends

MeasureValue
Dividend Per Share4.75
Dividend Yield3.31%
Dividend Growth (YoY)n/a
Years of Dividend Growth1
Payout Ratio2.45%
FCF Payout Ratio66.22%
Buyback Yieldn/a
Shareholder Yield3.31%
Earnings Yield13.49%
FCF Yield11.30%

Analystforecasts

MeasureValue
Price Target198.55
Price Target Difference38.17%
Analyst ConsensusStrong Buy
Analyst Count2
Revenue Growth Forecast (3Y)11.84%
EPS Growth Forecast (3Y)18.59%

Stocksplits

MeasureValue
Last Split DateNov 26, 2020
Split TypeForward
Split Ratio1.1

Scores

MeasureValue
Altman Z-Score4.3
Piotroski F-Score8

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside